Rx Price Reforms: PART I: We Already KNOW what DOESN’T Work
By Health Tech GPS |
When it comes to controlling costs for prescription drugs, everybody wants to get into the act this year. With so ...
Biosimilars: Reading FDA’s Tea Leaves
By Health Tech GPS |
When biosimilars hit FDA, what will be the review criteria? Everyone cares, since so much is at stake. The market ...
From the President’s Desk
By Health Tech GPS |
Those who know me will raise an eyebrow, even drop a jaw, at hearing of the evolution from solo-based consulting ...
Medical Devices: Next on the Chopping Block?
By Health Tech GPS |
Folks may just waking up to the impact that health reform will have on their businesses. Not just doctors or ...